BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

USA Nasdaq NASDAQ:BLMN • US0942351083

7.18 USD
+0.11 (+1.56%)
Last: Feb 9, 2026, 09:51 AM
Fundamental Rating

3

BLMN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 131 industry peers in the Hotels, Restaurants & Leisure industry. BLMN has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLMN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BLMN was profitable.
  • In the past year BLMN had a positive cash flow from operations.
  • In multiple years BLMN reported negative net income over the last 5 years.
  • BLMN had a positive operating cash flow in each of the past 5 years.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

  • The Return On Assets of BLMN (-1.76%) is worse than 68.70% of its industry peers.
  • The Return On Equity of BLMN (-16.78%) is comparable to the rest of the industry.
  • BLMN's Return On Invested Capital of 3.69% is in line compared to the rest of the industry. BLMN outperforms 41.98% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BLMN is in line with the industry average of 10.42%.
  • The 3 year average ROIC (9.55%) for BLMN is well above the current ROIC(3.69%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.76%
ROE -16.78%
ROIC 3.69%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • BLMN has a worse Operating Margin (3.27%) than 68.70% of its industry peers.
  • In the last couple of years the Operating Margin of BLMN has grown nicely.
  • BLMN has a Gross Margin of 71.04%. This is amongst the best in the industry. BLMN outperforms 87.02% of its industry peers.
  • BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.27%
PM (TTM) N/A
GM 71.04%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

  • BLMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • BLMN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BLMN has less shares outstanding
  • The debt/assets ratio for BLMN is higher compared to a year ago.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • BLMN has an Altman-Z score of 0.79. This is a bad value and indicates that BLMN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.79, BLMN is doing worse than 67.94% of the companies in the same industry.
  • BLMN has a debt to FCF ratio of 7.46. This is a slightly negative value and a sign of low solvency as BLMN would need 7.46 years to pay back of all of its debts.
  • BLMN has a Debt to FCF ratio of 7.46. This is in the better half of the industry: BLMN outperforms 70.23% of its industry peers.
  • BLMN has a Debt/Equity ratio of 2.82. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.82, BLMN perfoms like the industry average, outperforming 44.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.82
Debt/FCF 7.46
Altman-Z 0.79
ROIC/WACC0.45
WACC8.14%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.45 indicates that BLMN may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.45, BLMN is doing worse than 77.86% of the companies in the same industry.
  • A Quick Ratio of 0.38 indicates that BLMN may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.38, BLMN is not doing good in the industry: 78.63% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.38
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

  • The earnings per share for BLMN have decreased strongly by -41.47% in the last year.
  • Measured over the past 5 years, BLMN shows a small growth in Earnings Per Share. The EPS has been growing by 3.30% on average per year.
  • Looking at the last year, BLMN shows a very negative growth in Revenue. The Revenue has decreased by -21.31% in the last year.
  • The Revenue has been decreasing by -0.93% on average over the past years.
EPS 1Y (TTM)-41.47%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-114.29%
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.59%

3.2 Future

  • BLMN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -12.80% yearly.
  • The Revenue is expected to decrease by -1.91% on average over the next years.
EPS Next Y-36.4%
EPS Next 2Y-30.02%
EPS Next 3Y-15.45%
EPS Next 5Y-12.8%
Revenue Next Year-10.69%
Revenue Next 2Y-5.33%
Revenue Next 3Y-2.88%
Revenue Next 5Y-1.91%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.65, which indicates a rather cheap valuation of BLMN.
  • Based on the Price/Earnings ratio, BLMN is valued cheaper than 98.47% of the companies in the same industry.
  • BLMN is valuated cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 8.15, the valuation of BLMN can be described as very reasonable.
  • BLMN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLMN is cheaper than 94.66% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.77. BLMN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.65
Fwd PE 8.15
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 92.37% of the companies in the same industry are more expensive than BLMN, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.68
EV/EBITDA 5.46
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • BLMN's earnings are expected to decrease with -15.45% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.71
EPS Next 2Y-30.02%
EPS Next 3Y-15.45%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.36%, BLMN is a good candidate for dividend investing.
  • BLMN's Dividend Yield is rather good when compared to the industry average which is at 1.26. BLMN pays more dividend than 96.18% of the companies in the same industry.
  • BLMN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 6.36%

5.2 History

  • On average, the dividend of BLMN grows each year by 19.12%, which is quite nice.
  • BLMN has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-101.52%
EPS Next 2Y-30.02%
EPS Next 3Y-15.45%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (2/9/2026, 9:51:09 AM)

7.18

+0.11 (+1.56%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06
Earnings (Next)02-25
Inst Owners104%
Inst Owner Change-1.79%
Ins Owners1.77%
Ins Owner Change8.31%
Market Cap611.88M
Revenue(TTM)3.58B
Net Income(TTM)-57.75M
Analysts69
Price Target7.63 (6.27%)
Short Float %9.72%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 6.36%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-101.52%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.74%
Min EPS beat(2)13.79%
Max EPS beat(2)75.69%
EPS beat(4)4
Avg EPS beat(4)24.03%
Min EPS beat(4)2.96%
Max EPS beat(4)75.69%
EPS beat(8)6
Avg EPS beat(8)10.23%
EPS beat(12)10
Avg EPS beat(12)9.31%
EPS beat(16)14
Avg EPS beat(16)8.73%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-0.65%
Max Revenue beat(4)0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)2
Avg Revenue beat(12)-1.53%
Revenue beat(16)3
Avg Revenue beat(16)-1.36%
PT rev (1m)-2.53%
PT rev (3m)-3.23%
EPS NQ rev (1m)-0.22%
EPS NQ rev (3m)-1.75%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)7.54%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 5.65
Fwd PE 8.15
P/S 0.17
P/FCF 4.68
P/OCF 2.21
P/B 1.78
P/tB N/A
EV/EBITDA 5.46
EPS(TTM)1.27
EY17.69%
EPS(NY)0.88
Fwd EY12.28%
FCF(TTM)1.53
FCFY21.37%
OCF(TTM)3.25
OCFY45.32%
SpS41.99
BVpS4.04
TBVpS-3.73
PEG (NY)N/A
PEG (5Y)1.71
Graham Number10.74
Profitability
Industry RankSector Rank
ROA -1.76%
ROE -16.78%
ROCE 4.67%
ROIC 3.69%
ROICexc 3.79%
ROICexgc 5.2%
OM 3.27%
PM (TTM) N/A
GM 71.04%
FCFM 3.65%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexgc growth 3Y-22.65%
ROICexgc growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 2.82
Debt/FCF 7.46
Debt/EBITDA 3.51
Cap/Depr 91.54%
Cap/Sales 4.09%
Interest Coverage 2.01
Cash Conversion 100.12%
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.38
Altman-Z 0.79
F-Score6
WACC8.14%
ROIC/WACC0.45
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.47%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-114.29%
EPS Next Y-36.4%
EPS Next 2Y-30.02%
EPS Next 3Y-15.45%
EPS Next 5Y-12.8%
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.59%
Revenue Next Year-10.69%
Revenue Next 2Y-5.33%
Revenue Next 3Y-2.88%
Revenue Next 5Y-1.91%
EBIT growth 1Y-55.86%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year22.71%
EBIT Next 3Y7.53%
EBIT Next 5Y6.06%
FCF growth 1Y-19.47%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-41.24%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%

BLOOMIN' BRANDS INC / BLMN FAQ

What is the ChartMill fundamental rating of BLOOMIN' BRANDS INC (BLMN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLMN.


Can you provide the valuation status for BLOOMIN' BRANDS INC?

ChartMill assigns a valuation rating of 7 / 10 to BLOOMIN' BRANDS INC (BLMN). This can be considered as Undervalued.


How profitable is BLOOMIN' BRANDS INC (BLMN) stock?

BLOOMIN' BRANDS INC (BLMN) has a profitability rating of 4 / 10.


Can you provide the financial health for BLMN stock?

The financial health rating of BLOOMIN' BRANDS INC (BLMN) is 2 / 10.


How sustainable is the dividend of BLOOMIN' BRANDS INC (BLMN) stock?

The dividend rating of BLOOMIN' BRANDS INC (BLMN) is 6 / 10 and the dividend payout ratio is -101.52%.